CBPO  China Biologic Products Inc.

Exchange

NASDAQ

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Market Cap.

2.96B

Vuru Grade

67.23/100

Current Price

$119.02
+4.61 (+4.03%)

Growth Price

$42.48
Overvalued by 64.31%

Stability Price

$19.78
Overvalued by 83.38%

Company Metrics

  • 41.14 P/E
  • 11.05 P/S
  • 12.01 P/B
  • 2.89 EPS
  • 31.13% Cash ROIC
  • 0.67 Cash Ratio
  • 0 / N/A % Dividend
  • 198,783.00 Avg. Vol.
  • 24.87M Shares
  • 2.96B Market Cap.

Company Description

China Biologic Products, Inc., a biopharmaceutical company, engages in the research, development, production, and manufacture of plasma-based pharmaceutical products in the People's Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Investor Insights on China Biologic Products Inc (NASDAQ:CBPO)
Markets Wired - 12 hours ago
[PRNewswire] China Biologic Products Inc (NASDAQ:CBPO)(TREND ANALYSIS) a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its second quarter 2015 financial results on ...
Mid-Day Changers: China Biologic Products, Inc. (CBPO), Bellicum ... - WallStreet Scope
Bank of America Rating Update on China Biologic Products, Inc. (NASDAQ:CBPO)
Money Flow Index - Jul 21, 2015
Bank of America initiates coverage on China Biologic Products, Inc. (NASDAQ:CBPO). In the research report, Bank of America announces the target price to $135 per share on the shares.
Analyst Focus: China Biologic Products, Inc. (NASDAQ:CBPO) - Markets Daily
Zacks: Analysts Give $106.33 Consensus Price Target to China Biologic Products ... - WKRB News
China Biologic Products, Inc. (NASDAQ:CBPO) is Expected to Report $0.86 for Q1
Markets Daily - Jul 27, 2015
According to analysts, China Biologic Products, Inc. (NASDAQ:CBPO) is expected to report earnings per share for the current fiscal quarter of $0.86.
Company Shares of China Biologic Products, Inc. Drops by -1.13% - American Trade Journal
Market Movers: China Biologic Products, Inc. (NASDAQ:CBPO), Sprint Corporation ... - Stock Transcript
New Lifetime High For China Biologic Products (CBPO)
TheStreet.com - May 29, 2015
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
Stock in Focus : China Biologic Products, Inc. (NASDAQ:CBPO)
Markets Wired - Feb 18, 2015
China Biologic Products, Inc. (NASDAQ:CBPO) (TREND ANALYSIS) shares were traded with more than 50% increase in usual volume.
China Biologic Products to Report Second Quarter 2015 Financial Results
MarketWatch - Jul 23, 2015
BEIJING, July 24, 2015 /PRNewswire/ -- China Biologic Products, Inc. CBPO, -1.46% a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its second quarter 2015 financial results ...
China Biologic Products Inc Bearish Signal Wp X Biologics Llc decreased Stake
OctaFinance.com - Jun 16, 2015
Wp X Biologics Llc has filled a SC 13D/A form regarding China Biologic Products, Inc 116.98 -1.73 -1.46% . Filing Link: 000119312515224772.
Form 8-K China Biologic Products, For: Jun 15 - StreetInsider.com
China Biologic Products, Inc. Analyst Rating Update
Insider Trading Report - Jun 11, 2015
Analysts at Zacks have given a short term rating of strong buy on China Biologic Products (NASDAQ:CBPO) with a rank of 1. The company has received an average rating of 1 from 2 brokerage firms. 2 analysts have rated the company as a strong buy. China ...
China Biologic Announces Pricing of Public Offering of Common Stock - PR Newswire (press release)
Moving Stocks: China Biologic Products, Inc. (NASDAQ:CBPO), The Men's ... - StreetWise Report
New Lifetime High Reached By China Biologic Products (CBPO)
TheStreet.com - Mar 27, 2015
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
Today China Biologic Products (CBPO) Hits New Lifetime High
TheStreet.com - May 11, 2015
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.